Prebiotics and type 2 diabetes: targeting the gut microbiota for improved glycaemic control?
- 1 July 2020
- journal article
- review article
- Published by Wiley in Practical Diabetes
- Vol. 37 (4) , 133-137
Abstract
Changes to the gut microbiota are reported in type 2 diabetes. The activity of the microbiota is integral in maintaining intestinal barrier function, disruption to which is proposed as a risk factor for the low‐grade inflammation associated with insulin resistance. Can we target the microbiota through diet, and more specifically with prebiotics to improve barrier function and ultimately glycaemic control? This narrative review will discuss the evidence for barrier dysfunction in human type 2 diabetes and outline the recent evidence from clinical trials investigating the efficacy of prebiotics in glucose management. Copyright © 2020 John Wiley & Sons.Keywords
This publication has 27 references indexed in Scilit:
- Increased intestinal permeability as a risk factor for type 2 diabetesDiabetes & Metabolism, 2017
- Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patientsDiabetes Research and Clinical Practice, 2014
- Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebioticsBeneficial Microbes, 2014
- Increased intestinal permeability to oral chromium (51Cr) ‐EDTA in human Type 2 diabetesDiabetic Medicine, 2013
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell MonolayersThe Journal of Nutrition, 2009
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic populationAtherosclerosis, 2009
- Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequencesAmino Acids, 2006
- Presence of Inulin and Oligofructose in the Diets of AmericansThe Journal of Nutrition, 1999